These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36830314)

  • 1. Carbapenem-Resistant
    Madney Y; Aboubakr S; Khedr R; Hafez H; Ahmed N; Elsheshtawy K; Elanany M; Salahelden A; Shalaby L; Galal Behairy O
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
    Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
    Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
    Li C; Li Y; Zhao Z; Liu Q; Li B
    J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases.
    Liu LP; Lin QS; Yang WY; Chen XJ; Liu F; Chen X; Ren YY; Ruan M; Chen YM; Zhang L; Zou Y; Guo Y; Zhu XF
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):66. PubMed ID: 37422680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant
    Zhu Y; Xiao T; Wang Y; Yang K; Zhou Y; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2021; 14():5385-5393. PubMed ID: 34938086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    Ara-Montojo MF; Escosa-García L; Alguacil-Guillén M; Seara N; Zozaya C; Plaza D; Schuffelmann-Gutiérrez C; de la Vega Á; Fernández-Camblor C; Ramos-Boluda E; Romero-Gómez MP; Ruiz-Carrascoso G; Losantos-García I; Mellado-Peña MJ; Gómez-Gil R
    J Antimicrob Chemother; 2021 Jan; 76(1):220-225. PubMed ID: 33038895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India.
    Khare V; Gupta P; Haider F; Begum R
    J Clin Diagn Res; 2017 Mar; 11(3):DC18-DC21. PubMed ID: 28511383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study.
    Chu W; Hang X; Li X; Ye N; Tang W; Zhang Y; Yang X; Yang M; Wang Y; Liu Z; Zhou Q
    Infect Drug Resist; 2022; 15():6051-6063. PubMed ID: 36277248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant
    Ahn JY; Ahn SM; Kim JH; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song JE
    Microorganisms; 2023 Apr; 11(5):. PubMed ID: 37317095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
    Lu L; Xu C; Tang Y; Wang L; Cheng Q; Chen X; Zhang J; Li Y; Xiao H; Li X
    Infect Drug Resist; 2022; 15():2901-2914. PubMed ID: 35693849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Mortality and Drug Resistance Among Carbapenem-Resistant Enterobacteriaceae-Infected Pancreatic Necrosis Patients.
    Wu D; Xiao J; Ding J; Jia Y; Guo Z; Liu H; Peng J
    Infect Dis Ther; 2021 Sep; 10(3):1665-1676. PubMed ID: 34215975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
    Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].
    Huang XL; Wu SH; Shi PF; Xu LH; Chen C; Xie YP; Gao DQ; Chen K; Tan JF; Liu LR; Xu Y; Yang F; Yu MX; Wang SY; Qian SX
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):932-936. PubMed ID: 33333697
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.
    Khamis F; Al-Zakwani I; Molai M; Mohsin J; Al Dowaiki S; Al Bahrani M; Petersen E
    IJID Reg; 2022 Sep; 4():165-170. PubMed ID: 36059919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.